IP Library Granted Patent US 9,555,176
Granted Patent B2
US 9,555,176 · App. 14/307,608 · Granted Jan 31, 2017

Implantable device utilizing arterial deformation

Inventors: William Suttle Peters (Remuera, NZ); Scott Hugh Miller (Manly, AU); Peter Andew Watterson (West Ryde, AU)
Assignee: Sunshine Heart Company Pty, Ltd.
A61M1/107A61M1/1005A61M1/1044A61M1/1067A61M1/122A61M1/106A61M1/1072
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,555,176
App. No.
14/307,608
Granted
Jan 31, 2017
Kind
B2
Abstract

The present invention relates to deforming a patient's artery. In a preferred embodiment, the deformation pressure is applied to the outer wall of the artery.

Claims (35)

1. An implantable device, comprising:

(a) a substantially inelastic shell comprising an outer surface and an inner surface, wherein the shell is curved such that the inner surface is substantially concave;

(b) a flexible membrane sealingly coupled to the shell, wherein an inflatable space is defined between the flexible membrane and the inner surface, wherein the flexible membrane has a deflated configuration and an inflated configuration, wherein the inflated configuration is a smoothly curved ovate projection;

(c) a port associated with the outer surface of the shell, wherein an interior portion of the port is in fluid communication with the inflatable space; and

(d) a wrap coupled to the outer surface of the shell, the wrap configured to be removeably positionable around a portion of a patient's artery such that the flexible membrane is configured to be held against the artery, wherein the device has no other component or structure for holding the device against the artery,

wherein the shell is configured to extend around only a portion of the circumference of the artery.

2. The implantable device of claim 1 , wherein the flexible membrane is substantially inelastic.

3. The implantable device of claim 1 , wherein the port is configured to be coupleable to a motive component.

4. The implantable device of claim 1 , wherein a fluid is disposed within the inflatable space in the inflated configuration.

5. The implantable device of claim 4 , wherein the fluid is a liquid.

6. The implantable device of claim 1 , wherein the smooth curved ovate projection is configured to cause the artery to flex into a conic shape defined by a continuous line.

7. The implantable device of claim 1 , wherein the smooth curved ovate projection is configured to cause the artery to flex substantially without stretching a wall of the artery.

8. An implantable device, comprising:

(a) a substantially inelastic shell comprising an outer surface and an inner surface, wherein the shell is curved such that the inner surface is substantially concave;

(b) a flexible membrane sealingly coupled to the shell, wherein an inflatable space is defined between the flexible membrane and the inner surface, wherein the flexible membrane has a deflated configuration and an inflated configuration, wherein the inflated configuration is a smoothly curved oval projection;

(c) a port associated with the outer surface of the shell, wherein an interior portion of the port is in fluid communication with the inflatable space; and

(d) a wrap coupled to the outer surface of the shell, the wrap configured to be removeably positionable around a portion of a patient's artery such that the flexible membrane is configured to be held against an outer side of the artery, wherein the device has no other component or structure for holding the device against the artery,

wherein the smooth curved oval projection is configured to cause the outer side of the artery to progressively deform substantially without stretching a wall of the artery,

wherein the shell is configured to extend around only a portion of the circumference of the artery.

9. The implantable device of claim 8 , wherein the flexible membrane is substantially inelastic.

10. The implantable device of claim 8 , wherein the port is configured to be coupleable to a motive component.

11. The implantable device of claim 8 , wherein a fluid is disposed within the inflatable space in the inflated configuration.

12. The implantable device of claim 8 , wherein the smooth curved ovate projection is further configured to cause the outer side of the artery to progressively deform into a conic shape defined by a continuous line.

13. An implantable device, comprising:

(a) a shell comprising an outer surface and an inner surface, wherein the shell is curved such that the inner surface is substantially concave;

(b) a substantially inelastic flexible membrane sealingly coupled to the shell, wherein an inflatable space is defined between the flexible membrane and the inner surface, wherein the flexible membrane has a deflated configuration and an inflated configuration, wherein the inflated configuration is a smoothly curved oval projection, and further wherein the flexible membrane is configured to be positionable against an outer side of a patient's artery;

(c) a port associated with the outer surface of the shell, wherein an interior portion of the port is in fluid communication with the inflatable space; and

(d) a wrap coupled to the outer surface of the shell, wherein the wrap is removeably positionable around a portion of the artery such that the wrap holds the device against an outer side of the artery, wherein the device has no other component or structure for holding the device against the artery,

wherein the shell is configured to extend around only a portion of the circumference of the artery.

14. The implantable device of claim 13 , wherein the port is configured to be coupleable to a motive component.

15. The implantable device of claim 13 , wherein a fluid is disposed within the inflatable space in the inflated configuration.

16. The implantable device of claim 15 , wherein the fluid is a liquid.

17. The implantable device of claim 13 , wherein the smooth curved ovate projection is further configured to cause the outer side of the artery to progressively deform into the smoothly curved oval depression, wherein the smoothly curved oval depression is defined by a continuous line.

18. The implantable device of claim 13 , wherein the smooth curved ovate projection is configured to cause the outer side of the artery to progressively deform into the smoothly curved oval depression without stretching a wall of the artery.

19. The implantable device of claim 13 , wherein the smooth curved oval projection is configured to result in the outer side of the artery having a smoothly curved oval depression on an substantially unstretched wall of the artery.

Assignments (5)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 30, 2021
From: SUNSHINE HEART COMPANY PTY. LTD.
To: CHF SOLUTIONS, INC.
Reel/Frame 057041/0212 →
CHANGE OF NAME Recorded Jul 30, 2021
From: CHF SOLUTIONS, INC.
To: NUWELLIS, INC.
Reel/Frame 057047/0100 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: UNIVERSITY OF TECHNOLOGY, SYDNEY
To: SUNSHINE HEART COMPANY PTY, LTD.
Reel/Frame 040872/0227 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: PETERS, WILLIAM; MILLER, SCOTT H.
To: SUNSHINE HEART COMPANY PTY, LTD.
Reel/Frame 040872/0295 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jan 6, 2017
From: WATTERSON, PETER ANDREW
To: UNIVERSITY OF TECHNOLOGY, SYDNEY
Reel/Frame 040872/0405 →
Priority Claims (1)
AU 2002952691 · Nov 15, 2002 · national
Continuity (3)
Continuation 12044853 · Mar 7, 2008
Continuation 10702834 · Nov 5, 2003
Related Publication 20140296616A1 · Oct 2, 2014